Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review
Molecular Biology Reports December 1, 2020 Alec J. DiVito, Robert F. Leger
Classical psychedelics are a group of drugs characterized by their activation of the serotonin-2A (5-hydroxytryptamine-2A; 5-HT2A) receptor and the unique hallucinogenic and mystical-type experiences that result. After a substantial period of restrictions limiting investigations into the therapeutic potential of psychedelics, a relatively recent recommencement of interest has sparked the...
DOI: 10.1007/s11033-020-06009-x (opens in new tab)
Full text (opens in new tab)
Addiction
Smoking cessation
Psychedelics
Serotonergic hallucinogen